Skip to main content
Premium Trial:

Request an Annual Quote

WaferGen to Raise $30.4M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – WaferGen Biosystems today announced it has entered into definitive agreements to raise $30.4 million in a private placement financing of equity and debt.

The agreements are with Great Point Partners, Deerfield Management, and Merlin Nexus, as well as certain members of WaferGen's board and management.

Net proceeds will be used to expand commercialization of WaferGen's SmartChip Real-Time PCR system and related products, as well as for working capital and general corporate purposes.

"Our strategy is to accelerate the building of a sales force and distribution channels worldwide," Alnoor Shivji, chairman and CEO of WaferGen, said in a statement. "At the same time, in response to market demand, we plan to expand the applicability of this research tool to increase the number of genomic research disciplines that can benefit from the high-throughput SmartChip system."

The private placement consists of $15.2 million of non-voting convertible preferred stock and $15.2 million of non-voting convertible notes due November 2014.

The preferred stock is convertible into common stock at $.52 per share and has a coupon of 5 percent per year. The notes are convertible into non-voting convertible preferred stock, which may be convertible into common stock at $.57 per share and carry an interest rate of 5 percent annually.

Investors will also receive five-year warrants to buy about 56 million shares of common stock at an exercise price of $.62 per share.

Oppenheimer acted as lead placement agent for the financing.

In early trade on the OTC Bulletin Board, shares of WaferGen were up 7 percent at $.49.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.